Denali Capital Acquisition Corp.
Status: Live Deal
U=S+W
W=S@11.50
| IPO Proceeds, $M | $82.50M |
|---|---|
| IPO Date | Apr 7, 2022 |
| CEO | Lei Huang |
| Left Lead | Tiger Brokers |
| IPO Cash in Trust | 102.0% |
| SPAC Tenor | 12 + 3 + 3 + 9 + 9 |
| IPO Sector |
General
Technology, consumer and hospitality (excluding China, Hong Kong, and Macau) |
| IPO Geography | Global |
| Target Company | Semnur Pharmaceuticals |
| Deal Announced | Sep 3, 2024 |
| Deal Size, $M | TBD |
| Deal Sector | Healthcare |
| Deal Geography | US/Canada |
| SEC Filings | www.sec.gov |
| Approval Vote | TBD |
| Amendment Vote | Jul 10, 2024 |
DECA
DECAU
DECAW
| Price | $11.69 |
|---|---|
| Last closing price | $11.69 |
| H/L, today | $11.41 / $11.69 |
| H/L, 52-week | $9.82 / $11.84 |
| Volume, today | 2 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on Denali Capital Acquisition Corp.:
- Structure and cap table
- 5 directors & officers
- 51 filings and events
- 4 underwriters
- 2 legal advisors
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| Lei Huang | 51 | CEO and Director |
| You ("Patrick") Sun | 35 | CFO |
| Jim Mao | 54 | Director |
| Kevin Vassily | 56 | Director |
| Huifeng Chang | 56 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
| Tiger Brokers | Joint BR | 3,715,000 | units |
| EF Hutton | Joint BR | 780,000 | |
| US Tiger Securities | 3,000,000 | ||
| Joseph Gunnar | 5,000 | ||
| 7,500,000 | units | ||
| Up-Front UW fee | 2.00 | % | |
| Deferred UW fee |
3.50 | % |
Sign in to view more advisor data.